Cargando…

Targeting Myeloid Cells to the Brain Using Non-Myeloablative Conditioning

Bone marrow-derived cells (BMDCs) are able to colonize the central nervous system (CNS) at sites of damage. This ability makes BMDCs an ideal cellular vehicle for transferring therapeutic genes/molecules to the CNS. However, conditioning is required for bone marrow-derived myeloid cells to engraft i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Böttcher, Chotima, Fernández-Klett, Francisco, Gladow, Nadine, Rolfes, Simone, Priller, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820653/ https://www.ncbi.nlm.nih.gov/pubmed/24244666 http://dx.doi.org/10.1371/journal.pone.0080260

Ejemplares similares

The use and limitations of single‐cell mass cytometry for studying human microglia function
por: Fernández‐Zapata, Camila, et al.
Publicado: (2020)

1,2-(13)C(2)-Glucose Tracing Approach to Assess Metabolic Alterations of Human Monocytes under Neuroinflammatory Conditions
por: Giacomello, Ginevra, et al.
Publicado: (2023)

Comparison of Non-myeloablative Conditioning Regimens for Lymphoproliferative Disorders
por: Hong, Sanghee, et al.
Publicado: (2014)

The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
por: Zhu, Shengyun, et al.
Publicado: (2021)

Correction: The effects of myeloablative or non-myeloablative total body irradiations on intestinal tract in mice
Publicado: (2022)

Single-cell mass cytometry of microglia in major depressive disorder reveals a non-inflammatory phenotype with increased homeostatic marker expression
por: Böttcher, Chotima, et al.
Publicado: (2020)

Immune modulatory effect of a novel 4,5-dihydroxy-3,3´,4´-trimethoxybibenzyl from Dendrobium lindleyi
por: Khoonrit, Pichayatri, et al.
Publicado: (2020)

Phenotypic comparison of human alveolar macrophages before and after in vivo rhinovirus 16 challenge
por: de Groot, Linsey E. S., et al.
Publicado: (2021)

Single-cell mass cytometry reveals complex myeloid cell composition in active lesions of progressive multiple sclerosis
por: Böttcher, Chotima, et al.
Publicado: (2020)

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction
por: van Balen, Peter, et al.
Publicado: (2018)

A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations
por: Atilla, Erden, et al.
Publicado: (2017)

Pharmacokinetics-adapted Busulfan-based myeloablative conditioning before unrelated umbilical cord blood transplantation for myeloid malignancies in children
por: Benadiba, Joy, et al.
Publicado: (2018)

Isotopic tracing of glucose metabolites in human monocytes to assess changes in inflammatory conditions
por: Giacomello, Ginevra, et al.
Publicado: (2022)

Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer’s disease
por: Fernández Zapata, Camila, et al.
Publicado: (2022)

Clinical Comparison of Non-Myeloablative Conditioning with Anti-Thymocyte Globulin and Fludarabine for Patients with Hematologic Malignancies
por: Li, Qingshan, et al.
Publicado: (2015)

Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
por: Wagner, John E., et al.
Publicado: (2021)

High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation
por: Nakamura, R, et al.
Publicado: (2002)

Mapping the origin and fate of myeloid cells in distinct compartments of the eye by single‐cell profiling
por: Wieghofer, Peter, et al.
Publicado: (2021)

Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study
por: Sun, Zimin, et al.
Publicado: (2018)

Reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for patients with myelofibrosis
por: Kim, Dong Hyun, et al.
Publicado: (2022)

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity
por: Stephens, Sarah J., et al.
Publicado: (2016)

Comparison of Myeloablative Versus Reduced-Intensity Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia: A Cohort Study
por: Çiftçiler, Rafiye, et al.
Publicado: (2019)

Reduced-intensity versus Myeloablative Conditioning Regimens for Younger Adults with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A systematic review and meta-analysis
por: Ma, Shengling, et al.
Publicado: (2020)

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
por: Solomon, Scott R., et al.
Publicado: (2016)

Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
por: Byun, Hwa Kyung, et al.
Publicado: (2017)

Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
por: Bremer, Sara, et al.
Publicado: (2015)

Denser brain capillary network with preserved pericytes in Alzheimer's disease
por: Fernandez‐Klett, Francisco, et al.
Publicado: (2020)

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: improved outcomes over two decades
por: Cooper, Jason P., et al.
Publicado: (2020)

Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia
por: Byun, Ja Min, et al.
Publicado: (2020)

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
por: Campbell, P, et al.
Publicado: (2014)

On the trail of the obesity paradox
por: Gladow, Nadine, et al.
Publicado: (2022)

Neogenesis of cerebellar Purkinje neurons from gene-marked bone marrow cells in vivo
por: Priller, Josef, et al.
Publicado: (2001)

CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity
por: Bueno, Clara, et al.
Publicado: (2019)

Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia
por: Ogawa, Hiroaki, et al.
Publicado: (2022)

Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis
por: Böttcher, Chotima, et al.
Publicado: (2019)

Unrelated Bone Marrow Transplantation with a Reduced Toxicity Myeloablative Conditioning Regimen in Wiskott-Aldrich Syndrome
por: Kang, Hyoung Jin, et al.
Publicado: (2008)

Allogeneic hematopoietic stem cell transplantation in congenital hemoglobinopathies with myeloablative conditioning and rabbit anti-thymocyte globulin
por: Park, Bo-Kyoung, et al.
Publicado: (2018)

Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
por: Willasch, Andre Manfred, et al.
Publicado: (2020)

Across the Myeloablative Spectrum: Hematopoietic Cell Transplant Conditioning Regimens for Pediatric Patients with Sickle Cell Disease
por: Limerick, Emily, et al.
Publicado: (2022)

Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
por: Cao, Xing-yu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tdlgdhtmr6m2jm2chdvn01me1a